Stem cell exosomes for diabetic foot treatment
Part of Heart & circulation, Hormones & metabolism, Skin clinical trials.
This trial tests a new treatment using stem cell-derived exosomes (tiny particles that help cells communicate) to heal diabetic foot ulcers. It aims to see if this approach is safe and effective for people with diabetic foot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of diabetic foot.
- You are between 18 and 90 years old.
- You are able to do most daily activities on your own (ECOG score less than 4).
- Your blood counts and liver/kidney function are within safe limits (based on recent blood tests).
- You are willing to follow the study schedule and tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether stem cells taken from fat tissue (after a small procedure) can help heal a long-lasting diabetic foot ulcer. It mainly aims to help ulcers that are limited to soft tissue and have good blood flow to the foot.
This trial compares several advanced wound treatments (called CAMPs) plus standard care versus standard care alone for diabetic foot ulcers that are slow to heal. The goal is to see if adding these treatments helps ulcers close faster.
This trial tests a new cell treatment for diabetic foot ulcers by injecting special regulatory monocytes (OPM cells) to help heal wounds. It is for patients with mild to moderate ulcers that haven't healed for over a month.
This trial tests whether injecting your own fat stem cells into a diabetic foot ulcer can help it heal. It is for people with a specific type of foot sore that hasn't healed after 6 weeks of standard care.
This trial tests if a type of stem cell product (exosomes) can safely and effectively help people with type 2 diabetes. Researchers will give infusions to see if it improves blood sugar control and pancreatic function.
This trial tests whether a treatment made from stem cells and their cell messengers (exosomes) can help men with diabetes and erectile dysfunction who have not been helped by standard treatments. The goal is to see if this therapy can improve erections and offer a less invasive option than a penile implant.
Hear when a new Diabetic Foot trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.